Cancer Research UK logo.
SearchDonate
  • Search

A trial of atorvastatin and hormone therapy for prostate cancer (SPECTRE)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 2

Details

This trial was done to see if adding atorvastatin to hormone therapy can slow down the growth of prostate cancer.

It was open for people to join between 2017 and 2019. The team analysed the results in 2020.

Recruitment start: 1 January 2017

Recruitment end: 31 July 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Hing Leung

Supported by

CRUK Glasgow Clinical Trials Unit

NHS Greater Glasgow and Clyde

Prostate Cancer UK

University of Glasgow

Last reviewed: 15 May 2024

CRUK internal database number: 13881

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.